National Institute for Health and Care Excellence1 个月
Tebentafusp for treating advanced uveal melanoma
NICE has recommended tebentafusp as an option for treating HLA-A*02:01-positive unresectable or metastatic uveal melanoma in adults. Tebentafusp is only recommended if the company provides it ...
National Institute for Health and Care Excellence1 个月
Tebentafusp for treating advanced uveal melanoma
Tebentafusp (Kimmtrak, Immunocore) is indicated 'as monotherapy for the treatment of human leukocyte antigen (HLA)‑A*02:01-positive adult patients with unresectable or metastatic uveal melanoma'. The ...